SunVax mRNA Therapeutics
Biotechnology company developing mRNA therapeutics through lipid nanoparticle delivery and self-amplifying mRNA technologies. The organization focuses on delivery specificity, payload amplification, and platform integration to enable applications in immuno-oncology, vaccines, autoimmune and rare diseases. Offers research-use delivery kits and publishes technical data on platform performance.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Synthetic self-amplifying MRNA molecules with secretion antigen and immunomodulator
US-12416032-B2
View DetailsSynthetic self-amplifying mRNA molecules with secretion antigen and immunomodulator
US-12084703-B2
View Details
Synthetic self-amplifying MRNA molecules with secretion antigen and immunomodulator
US-12416032-B2
View DetailsSynthetic self-amplifying mRNA molecules with secretion antigen and immunomodulator
US-12084703-B2
View DetailsProducts
Lipid nanoparticle delivery platform (technical disclosure)
Technical disclosure and documentation describing the company's lipid nanoparticle design and formulation approaches.
Self-amplifying mRNA platform (technical disclosure)
Documentation describing self-amplifying mRNA strategies that encode replicase machinery to amplify intracellular expression.
Cascade amplification platform (published paper PDF)
Published technical paper describing cascade amplification of therapeutic payloads combining delivery, self-amplifying payloads, and amplification cascades.
Lipid nanoparticle delivery platform (technical disclosure)
Technical disclosure and documentation describing the company's lipid nanoparticle design and formulation approaches.
Self-amplifying mRNA platform (technical disclosure)
Documentation describing self-amplifying mRNA strategies that encode replicase machinery to amplify intracellular expression.
Cascade amplification platform (published paper PDF)
Published technical paper describing cascade amplification of therapeutic payloads combining delivery, self-amplifying payloads, and amplification cascades.
Services
Research-use kits designed to enable targeted mRNA delivery to specific cell types for preclinical experiments.
Research-use kits designed to direct mRNA therapeutics to specific tissues (examples cited: liver, lymphatic system).
Research-use kits designed to enable targeted mRNA delivery to specific cell types for preclinical experiments.
Research-use kits designed to direct mRNA therapeutics to specific tissues (examples cited: liver, lymphatic system).
Expertise Areas
- mRNA therapeutics
- Lipid nanoparticle delivery systems
- Targeted delivery (cell- and tissue-specific)
- Self-amplifying mRNA platforms
Key Technologies
- Lipid nanoparticles (LNPs)
- Self-amplifying mRNA
- Ionizable lipid libraries
- High-throughput screening
News & Updates
Published article/paper describing a cascade amplification approach combining delivery systems and self-amplifying mRNA to increase in situ expression.
Published article/paper describing a cascade amplification approach combining delivery systems and self-amplifying mRNA to increase in situ expression.